The exceptional result of this unique technology.

 

The mechanical support offered by the product to restore the firmness and rebuild its lost density due to the loss of HA.

This unique and patented technology gives rise to a particularly cohesive monophasic gel with essential qualities.

  • Easier and faster injections without compromising the quality of the product.

  • Injections that do not require overcorrection.

Distinguished rheology.

Cohesive nature of the monophasic product.

 

Dispersive nature of the biphasic product.

 

The formation of a monoblock interdermal implant.

After 24 Hrs - Slight chronic inflammation.

 

 

 

 

 

After 4 weeks - Biointegrated implant without any secondary reaction.

 

Delayed biodegredation of the injected product.

A considerably better result is seen in the initial months in terms of increased volume and wrinkle filling.

Esthelis is distributed by Pulmon Medical www.pulmonmedical.com